SURVIVAL AND GROWTH of the conceptus (embryo/fetus and placental membranes) is dependent on the uterus. During early pregnancy, the endometrium synthesizes and secretes, as well as selectively transports, a variety of substances, collectively termed histotroph, into the uterine lumen (7, 70) . Histotroph is a complex mixture of serum proteins, transport proteins, adhesion proteins, protease inhibitors, cytokines, growth factors, hormones, amino acids, and ions (47) . Uterine secretions are of particular importance for survival and growth of conceptuses in domestic animals because of the protracted peri-implantation period and the superficial nature of implantation and placentation (7, 8, 70) . In sheep, morula-stage embryos enter the uterus on days 4 -5 postmating and develop into blastocysts by day 6 (32, 82) . After hatching from the zona pellucida on day 8, blastocysts develop into a tubular form by day 12 (1.5-2 cm in length) and are now termed a conceptus. The conceptus begins to elongate on day 12 and forms a filamentous conceptus (10 cm or more in length) by day 14 that reaches 25 cm or more in length by day 17. Blastocyst elongation involves exponential increases in length and weight of the trophectoderm, as well as differentiation of the extraembryonic membranes (87) . Available evidence supports the hypothesis that survival, growth, and development of blastocysts requires histotroph in the uterine lumen that derives primarily from transport and/or secretion of substances by the endometrial luminal (LE) and glandular epithelia (GE). This hypothesis is supported by the inability of ovine blastocysts to elongate in culture (18) . Further, uterine gland knockout (UGKO) ewes, lacking endometrial GE and with reduced LE, exhibit recurrent early pregnancy loss that manifests between days 12 and 14 postmating (30, 31) . However, knowledge of the specific components of histotroph and global patterns of endometrial gene expression during pregnancy in ruminants is limited (see Refs. 81, 84 for review).
During early pregnancy, endometrial functions are regulated primarily by progesterone (P4) from the corpus luteum and secreted cytokines and hormones from the trophectoderm/ chorion, including interferon tau (IFNT) in ruminants (8, 83, 84) . In sheep, establishment of pregnancy requires blastocyst elongation between days 12 and 16 and production of IFNT (78) . IFNT exerts antiluteolytic effects on the endometrium to inhibit development of the luteolytic mechanism, thereby maintaining corpus luteum function and ensuring continued production of P4. Progesterone stimulates and maintains uterine endometrial functions necessary for conceptus growth, implantation, placentation, and successful development of the fetus to term (7, 83) . The postovulatory rise in circulating P4 during early pregnancy clearly affects blastocyst growth in cattle (60) . Increasing concentrations of P4 during metestrus and early diestrus enhanced blastocyst development and size by days [13] [14] [15] [16] in heifers and cows (12, 23, 59) , while animals with lower concentrations of P4 in the early luteal phase had retarded embryonic development (61, 66) and conceptuses produced less IFNT (61) . Studies of both sheep and cattle are beginning to identify pregnancy and P4-responsive genes in the endometrium that potentially regulate blastocyst elongation and implantation of the conceptus (see Refs. 5, 81, 84 for review).
We recently reported results from a study of an ovine model of accelerated blastocyst development elicited by advancing the postovulatory rise in circulating levels of P4 during metestrus (72) . In that model, exogenous injections of P4 are initiated on day 1.5 postmating that causes an increase in blastocyst size on day 9 and advances development of the normally ovoid conceptus into an elongated filamentous conceptus on day 12 (72) . That study also demonstrated that P4 is essential for blastocyst survival and growth in sheep, because treatment of ewes with mifepristone (RU486), a progesterone receptor (PGR) and glucocorticoid receptor (GR) antagonist (6) , from days 8 to 12 compromised blastocyst survival (72) . Available evidence supports the hypothesis that effects of P4 on preimplantation growth and development of blastocysts are indirect and primarily mediated by changes in endometrial gene expression. Therefore, this study determined effects of early P4 treatment on the endometrial transcriptome of pregnant ewes to identify novel candidate genes and regulatory pathways governing preimplantation blastocyst growth and development.
MATERIALS AND METHODS

Animals. Mature Suffolk ewes (Ovis aries)
were observed for estrus (designated as day 0) in the presence of a vasectomized ram and used in experiments only after exhibiting at least two estrous cycles of normal duration (16 -18 days) . All experimental and surgical procedures were in compliance with the Guide for the Care and Use of Agriculture Animals in Research and Teaching and approved by the Institutional Animal Care and Use Committee of Texas A&M University.
Experimental design and tissue collection. As described previously (72), ewes were mated at estrus to intact Suffolk rams and then assigned randomly to receive daily intramuscular (im) injections from days 1.5 to 9 of either corn oil (CO) vehicle or 25 mg progesterone (P4) (Sigma Chemical, St. Louis, MO) in CO vehicle and hysterectomized on either day 9 or day 12 of pregnancy (n ϭ 6 per day and treatment). At hysterectomy, sections (ϳ0.5 cm) from the midportion of each uterine horn ipsilateral to the corpus luteum were fixed in fresh 4% paraformaldehyde in PBS (pH 7.2). After 24 h, fixed tissues were changed to 70% ethanol for 24 h, dehydrated through a graded series of alcohol to xylene, and then embedded in Paraplast-Plus (Oxford Labware, St. Louis, MO). The remaining endometrium of the ipsilateral uterine horn was physically dissected from myometrium, frozen in liquid nitrogen, and stored at Ϫ80°C for subsequent RNA extraction. In monovulatory pregnant ewes, uterine tissue samples were marked as either contralateral or ipsilateral to the ovary bearing the corpus luteum. No tissues from the contralateral uterine horn were used for further analysis.
RNA isolation. Total cellular RNA was isolated from frozen ipsilateral endometrium using TRIzol reagent (GIBCO-BRL, Bethesda, MD) according to manufacturer's instructions. The quantity and quality of total RNA were determined by spectrometry and Agilent BioAnalyzer 2100 (Agilent, Palo Alto, CA) using the RNA 6000 Nano Labchip kit (Agilent), respectively, in accordance with the manufacturer's instructions. Endometrial RNA was subsequently processed through an RNeasy Mini Kit (Qiagen, Valencia, CA) according to manufacturer's instructions.
Microarray analysis. Microarray hybridization was conducted with a bovine whole genome spotted oligonucleotide array. This 24,000-element array was developed by the Bovine Oligo Microarray Consortium at the University of Missouri in collaboration with Texas A&M University and Iowa State University (see http://www.bovineoligo.org). The array includes 16,846 probes designed from expressed sequence tags (ESTs) that were aligned to homologous vertebrate proteins and to the 6X bovine genome assembly. The probe set was supplemented with oligos designed from 703 predicted RefSeq genes and 5,943 reproductive tissue ESTs. A link to probe sequences and annotations is available at http://www.bovineoligo.org. The annotation included assigning a human gene symbol based on homology using BLAST (2) . The oligos were synthesized by Illumina and spotted onto aminosilane-coated glass slides by Dr. David Galbraith's laboratory at the University of Arizona (http://www.ag.arizona.edu/microarray/BOM. html).
cDNA synthesis and hybridization. Hybridizations were performed with the Genisphere Array 350 kit (Genisphere, Hatfield, PA) using dual channel design with dye-swapping. Preparation of cDNA was performed according to the manufacturer's instructions. Briefly, endometrial total RNA (9 g) from each ewe (n ϭ 6 per day and treatment) was reverse-transcribed with Superscript II (Invitrogen, Carlsbad, CA) with the Genisphere oligo d(T) primer containing a capture sequence for the Cy3 or Cy5 labeling reagents. Each cDNA sample containing the capture sequence for the Cy3 or Cy5 label was cohybridized with a cDNA sample from the opposite treatment for direct comparison of differences between treatments.
Microarray slides were prepared by being placed ϳ6 -8 cm above a 50°C water bath for 10 s followed by snap-drying on a heat block at 65°C for 5 s and then allowing them to cool at room temperature for 1 min; this process was repeated four times for each slide. Slides were then UV cross-linked at 1,800 J. Following UV cross-linking, slides were washed in 1% SDS (Ambion, Austin, TX) for 5 min on a gently rotating platform, rinsed twice in nuclease-free water (Invitrogen), and subsequently washed for 3 min in 100% ethanol with gentle agitation. Slides were then placed in 50 ml conical tubes and dried by centrifugation at Ͻ1,000 g for 4 min. Dried slides were stored in a light-tight slide box until hybridization. At the time of hybridization, 130 l of concentrated cDNA (combined samples) was mixed with 2 l LNA dT blocker, 118 l nuclease-free water, and 250 l 2X Enhanced Hybridization Buffer (Genisphere) and denatured at 80°C for 10 min. An Agilent gasket slide was utilized for the first hybridization step. Following assembly of the hybridization chamber, slides were hybridized at 58°C for 16 h. Slides were washed and dried according to manufacturer's instructions, and a second hybridization reagent containing the capture reagents was made according to instructions. All subsequent steps were performed under minimal light conditions. Dried slides were then hybridized with 50 l of the 3DNA hybridization mix, coverslipped, placed in a humidified 50 ml conical tube and hybridized at 58°C for 4 h in the dark. Following removal of coverslips, slides were washed and dried according to manufacturer's instructions.
Imaging and microarray data acquisition. Arrays were scanned at 5 m resolution on a GenePix Personal 4100A (Molecular Devices, Sunnyvale, CA), and images were saved in the TIFF format. Auto photomultiplier tube (PMT) settings were selected and adjusted so that the ratio of overall intensities between two channels (Cy3 and Cy5) was 0.95 to 1.05. The signal intensities of all spots on each image were quantified by Genepix Pro 6.0 software (Molecular Devices, Downingtown, PA), and data were saved as .txt files for further analysis.
Normalization and statistical analysis. The signal intensity of each probe was divided by that of negative control to filter the genes that were not expressed. Signal intensities were normalized by LOWESS within the R statistics package (90) . To correct for background signal, median signal intensity and median background intensity were used to normalize the data by LOWESS (58 (15, 42) . DAVID was utilized to annotate biological themes in response to day of pregnancy (day 9 vs. day 12 in CO-treated ewes) or P4 treatment (CO vs. P4) within day of pregnancy. All differentially expressed genes identified to be both significantly (P Ͻ 0.05) and numerically (2-fold change) different for the three different comparisons and homologous to a known and annotated human gene were used in the DAVID analysis. The background list utilized in the program included all genes assigned a human accession number that were present on the bovine oligo array. With Gene Ontology (GO) terms as identified through biological process, cellular component, and molecular function as well as protein domain and biochemical pathway membership, biological themes were generated through DAVID by grouping like terms, thereby creating functional annotation clusters associated with effects of day of pregnancy and P4 treatment.
Cloning of partial cDNAs. Partial cDNAs were amplified by RT-PCR using endometrial total RNA isolated from day 16 or day 18 pregnant ewes and specific primers (Supplemental Table S1 1 ) using methods described previously (85) . PCR amplification was conducted as follows for ANPEP, MIF, NMB, AGR2, HSD11B1, CXCL14, EPSTI1, PLAC8, S100A2, and S100A4: 1) 95°C for 5 min; 2) 95°C for 30 s; 52.5°C for 1 min (HSD11B1, NMB, PLAC8), 55°C (for ANPEP, MIF, CXCL14, EPSTI1, S100A2, and S100A4), 56.5°C (for AGR2); and 72°C for 1 min for 35 cycles; and 3) 72°C for 10 min. The partial cDNAs of the correct predicted size were cloned into pCRII using a T/A Cloning Kit (Invitrogen) and the sequence of each verified by use of an ABI PRISM Dye Terminator Cycle Sequencing Kit and ABI PRISM automated DNA sequencer (Perkin-Elmer Applied Biosystems).
Slot blot hybridization analysis. Steady-state levels of mRNA in endometria were assessed by slot blot hybridization using radiolabeled cRNA probes as described previously (85) . To correct for variation in total RNA loading, a duplicate RNA slot blot membrane was hybridized with radiolabeled antisense 18S cRNA (pT718S; Ambion, Austin, TX). Slot blots were quantified using a Typhoon 8600 MultiImager (Molecular Dynamics, Piscataway, NJ), and data are expressed as relative units (RU) with standard error.
In situ hybridization analysis. Location of mRNAs in the ovine uterus was determined by radioactive in situ hybridization analysis as described previously (85) . Images of representative fields were recorded under bright-field or dark-field illumination using a Nikon Eclipse 1000 photomicroscope (Nikon Instruments, Lewisville, TX) fitted with a Nikon DXM1200 digital camera.
Statistical analyses. Data from slot blot hybridization analyses were subjected to least-squares analysis of variance using the General Linear Models procedures of the Statistical Analysis System (SAS Institute, Cary, NC). Slot blot hybridization data were corrected for differences in sample loading by using the 18S rRNA data as a covariate. Data are presented as the least-squares means (LSM) with overall standard error (SE).
RESULTS
We previously reported that exogenous injections of P4 in ewes, beginning on day 1.5 after mating, increased blastocyst diameter 2.2-fold on day 9, and accelerated the morphological transformation of spherical blastocysts into filamentous conceptuses on day 12 (38) .
Endometrial gene expression is altered by day of pregnancy and early P4 treatment. Microarray analysis was conducted to identify differences in the endometrial transcriptome between days 9 and 12 of pregnancy in CO-treated ewes and between P4 and CO-treated ewes on day 9 and day 12 of pregnancy (see Supplemental Tables S2-S4 for complete gene lists). In summary, 707 genes were at least twofold different (P Ͻ 0.05) between days 9 and 12 of pregnancy in control CO-treated ewes (411 genes were higher on day 12 or lower on day 9 and 296 genes were higher on day 9 or lower on day 12), 111 genes were different between CO-and P4-treated ewes on day 9 (62 genes were higher and 49 genes were lower), and 170 genes were different between CO-and P4-treated ewes on day 12 (101 genes were higher and 69 genes were lower). Genes that were co-regulated by day of pregnancy and early P4 treatment are presented in Venn diagrams (Figs. 1 and 2, respectively).
Validation of selected genes. Several of the genes identified by microarray analysis as upregulated in the endometrium between days 9 and 12 of early pregnancy and increased by early P4 treatment on day 9 and/or day 12 (see Supplemental  Tables S2-S4 ) have already been reported in the ovine uterus with similar changes in steady-state levels of endometrial mRNA determined by slot blot hybridization analysis or realtime PCR (84) . For instance, cathepsin L (CTSL); dickkopf homolog 1 (DKK1); gastrin releasing peptide (GRP); insulinlike growth factor binding protein 1 (IGFBP1); and lectin, galactoside-binding, soluble, 15 (LGALS15) mRNAs are upregulated between days 10 and 12 in both cyclic and pregnant ewes (21, 29, 73, 76) and increased by early P4 treatment on either day 9 and/or day 12 (72, 73) . Thus, these genes serve to validate results of the current results from microarray analyses.
For validation of several other genes from the microarray analyses, steady-state levels of endometrial mRNA were determined by slot blot hybridization analysis (see Fig. 3 and Table 1 ). Steady-state mRNA levels for several genes, alanyl (membrane) aminopeptidase (ANPEP), and macrophage migration inhibitory factor (glycosylation-inhibiting factor) (MIF) decreased (P Ͻ 0.05) between days 9 and 12 of pregnancy and decreased (P Ͻ 0.05) on day 9 in P4-treated ewes. Neuromedin B (NMB) mRNA levels were unaffected (P Ͼ 0.10) by day of pregnancy but decreased (P Ͻ 0.05) on day 12 in P4-treated ewes. Steady-state levels of chemokine (C-X-C motif) ligand 14 (CXCL14) mRNA increased (P Ͻ 0.05) between days 9 and 12 of pregnancy and increased (P Ͻ 0.05) on day 9 in P4-treated ewes. However, anterior gradient homolog 2 (Xenopus laevis) (AGR2) mRNA levels increased (P Ͻ 0.05) between days 9 and 12 of pregnancy and were greater (P Ͻ 0.05) on day 12 in P4-treated ewes. Interestingly, hydroxysteroid (11-beta) dehydrogenase 1 (HSD11B1) and solute carrier family 5 (sodium/glucose cotransporter) member 1 (SLC5A1) mRNA levels increased (P Ͻ 0.05) between days 9 and 12 of pregnancy and were greater (P Ͻ 0.05) on both days 9 and 12 in P4-treated ewes. In contrast, epithelial stromal interaction 1 (breast) (EPSTI1), placenta-specific 8 (PLAC8), 1 The online version of this article contains supplemental material. S100 calcium binding protein A2 (S100A2), and S100A4 mRNA levels were unaffected (P Ͼ 0.10) by day of pregnancy but were greater (P Ͻ 0.05) on day 12 in P4-treated ewes. Collectively, these results validate the regulation of genes predicted, based on transcriptional profiling analyses, to be affected by day of pregnancy and/or early P4 treatment, and they highlight the complex nature of changes in endometrial gene expression during this critical preimplantation period of pregnancy.
As expected, cell-specific differences in expression of the validated genes in the uterine endometrium were detected (see Fig. 4 ). ANPEP and MIF mRNAs were localized predominantly to the endometrial LE/sGE, while neuromedin B (NMB) mRNA was detected primarily in deep GE. PLAC8 mRNA was localized predominantly to the LE, although detectable in stromal cells and GE. S100A2 mRNA was detected only in LE/sGE, whereas S100A4 mRNA was detected primarily in the stratum compactum stroma and to a much lesser extent in LE. Tables S2-S4. Interestingly, S100A4 mRNA was also detected in endothelial cells, most notably within caruncles. HSD11B1 and SLC5A1 mRNA was observed only in endometrial LE/sGE. DAVID analysis. DAVID analysis was conducted to detect biological processes affected by day of pregnancy (day 9 vs. day 12) and early P4 treatment as assessed on day 9 and day 12. Spherical blastocysts begin to elongate on days 11-12 to form a filamentous conceptus by day 14 (84) . Growth and development of the blastocyst into an elongated, filamentous conceptus require the uterus (18) , particularly secretions from the endometrial epithelia (30) . DAVID analysis identified a number of differentially expressed genes between days 9 and 12 of early pregnancy in the endometrium that were associated with several biological themes including lipid biosynthesis and metabolism, von Willebrand factor domains, transport and transporter activity, extracellular space, inflammatory and defense response, cell development and differentiation, peptidase activity, and amino acid metabolism and transport (Table 2 and  Supplemental Table S5) .
DAVID analysis identified a number of differentially expressed genes between early P4-and CO-treated ewes on day 9 of early pregnancy in the endometrium that were associated with several biological themes including extracellular space, blood circulation, cell development and differentiation, inflammatory and defense response, transport and transporter activity, sugar and carbohydrate binding, and lipid biosynthesis and metabolism (Table 3 and Supplemental Table S6 ). Many of those same biological terms were also found in differentially expressed genes between days 9 and 12 of early pregnancy in CO-treated ewes.
DAVID analysis identified a number of differentially expressed genes between early P4-and CO-treated ewes on day 12 of early pregnancy in the endometrium that were associated with several biological themes including cell development and differentiation, WASP homology region 1 (WH1) domains, sugar and carbohydrate binding, glycerolipid metabolism, extracellular space, Sushi domains, signal transduction, reproductive processes, endocytosis, coagulation, tissue remodeling, and steroid hormone metabolism (Table 4 and Supplemental  Table S7 ).
DISCUSSION
In the present study, transcriptional profiling of the endometria in an ovine model of P4-induced acceleration of blastocyst development identified candidate genes that may regulate sur- vival, growth, and development of preimplantation blastocysts/ conceptuses. Genes that are coordinately increased or decreased between days 9 and 12 of pregnancy and by early P4 treatment are likely important for endometrial support of growth and development of blastocysts (see Figs. 1 and 2) . A comprehensive discussion of all genes in the endometrium affected by day of pregnancy and/or early P4 treatment is not possible. Therefore, the discussion will focus on groups of interrelated genes that likely form a physiological network important for endometrial function in sheep and, perhaps, other mammals. Analysis of gene regulation in endometria of several mammals, including sheep, primates, and humans, revealed that many genes are upregulated in endometria of both nonpregnant and pregnant individuals during diestrus (11, 41, 48) , because the uterine endometrium, under the influence of P4, prepares for establishment of pregnancy by the conceptus (1). Some of those genes are downregulated if the individual does not become pregnant, while others remain on or are stimulated by products of the conceptus trophectoderm, e.g., chorionic gonadotropin or IFNT, if the individual is pregnant. Therefore, the endometrium has an optimistic view that a blastocyst will be present each cycle.
Survival and growth of the preimplantation blastocyst clearly require the microenvironment of the lumen of the uterus. However, the composition of uterine histotroph is not well defined. Micronutrients provided by the endometrium are sourced from maternal serum via specific transporters across the endometrial epithelia and into the uterine lumen. In the present study, DAVID analysis identified transport and transporter activity as a biological process affected by day of pregnancy and early P4 treatment. Of particular note, transporters for glucose (SLC2A9, SLC5A1) and glucose and fructose (SLC2A5) were upregulated between days 9 and 12 of pregnancy. Glucose is the main substrate used by mammalian embryos as a source of energy and can be utilized anabolically to synthesize glycogen, nucleic acids, proteins, and lipids (69) . In ewes, the amount of glucose in the uterine lumen increases sixfold between days 10 and 15 of gestation (22) . Solute carrier family 2 (facilitated glucose transporter), member 9 (SLC2A9), and solute carrier family 2 (facilitated glucose/fructose transporter), member 5 (SLC2A5) have not been studied in the ovine uterus, but SLC5A1, a glucose transporter, is expressed specifically in ovine endometrial LE/sGE where it is induced by P4 and stimulated by IFNT (21) . Transporters for other micronutrients (fatty acids, nucleoside, choline, metal ion, aspartate, glutamate, sodium phosphate, potassium and chloride, and monoamine) were also differentially expressed in the endometrium between days 9 and 12 of pregnancy. However, only SLC11A2 [solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2] and SLC44A4 (solute carrier family 44, member 4), a choline transporter, were coordinately upregulated by day of pregnancy and early P4 treatment. Collectively, these results indicate that transporters expressed in the endometrium are important for tailoring the composition of micronutrients in uterine histotroph required to support blastocyst growth and rapid development into an elongated, filamentous conceptus.
In addition to the provision of select micronutrients such as glucose, ions, and amino acids, the endometrium synthesizes and secretes a number of growth factors and cytokines that are implicated in trophoblast proliferation, migration, and attachment, which are cellular processes involved in blastocyst growth and elongation (33, 82) . Indeed, functional annotation clusters identified by DAVID analysis included biological terms such as extracellular space, secreted, and response to stimulus as processes in the endometrium affected by day of pregnancy and early P4 treatment. Between days 9 and 12 of pregnancy, a number of factors that stimulate cellular proliferation, migration, and attachment were upregulated, including connective tissue growth factor (CTGF), ephrin-A1 (EFNA1), ephrin-B1 (EFNB1), GRP, IGFBP1, and LGALS15. The cell(s) expressing EFNA1 and EFNB1 in the ovine uterus are not known, but they are expressed in the epithelia of human and mouse endometria and implicated in blastocyst attachment and spreading (19, 20) . Both GRP and CTGF are expressed in ovine endometrial GE (28, 75) . CTGF stimulates cell proliferation, migration, adhesion, and extracellular matrix production Official gene symbols were used as abbreviations. ANPEP, alanyl (membrane) aminopeptidase; MIF, macrophage migration inhibitory factor (glycosylation-inhibiting factor); NMB, neuromedin B; AGR2, anterior gradient homolog 2 (Xenopus laevis); HSD11B1, hydroxysteroid (11-beta) dehydrogenase 1; CXCL14, chemokine (C-X-C motif) ligand 14; EPSTI1, epithelial stromal interaction 1 (breast); PLAC8, placenta-specific 8; S100A2, S100 calcium binding protein A2; S100A4, S100 calcium binding protein A4. P4, progesterone; CO, corn oil.
b Data are presented as fold change; *P Ͻ 0.01, †P Ͻ 0.05 for the comparison.
and functions in processes such as development, differentiation, angiogenesis, implantation, wound healing, and fibrosis (10) . GRP is expressed in ovine endometrial GE and is found in the uterine lumen (25, 75) . GRP can be processed into different forms that are potent mitogens for several types of carcinomas (67) . LGALS15, a secreted animal lectin found in the uterine lumen of the ovine and caprine uterus (29, 57) , contains an RGD integrin recognition and binding sequence and stimulates migration and adhesion of ovine trophectoderm cells in vitro (17, 57) . In addition to IGF ligand binding, (9) GO:0046942ϳcarboxylic acid transport (9) GO:0015813ϳL-glutamate transport (4) GO:0015800ϳacidic amino acid transport (4) GO:0015849ϳorganic acid transport (9) GO:0015171ϳamino acid transmembrane transporter activity (7) GO:0046943ϳcarboxylic acid transmembrane transporter activity (8) GO:0015179ϳL-amino acid transmembrane transporter activity (5) GO:0005342ϳorganic acid transmembrane transporter activity (8) GO:0015172ϳacidic amino acid transmembrane transporter activity (3) a The 15 most significant annotation clusters identified based on the gene list submitted for analysis through DAVID.
b The enrichment score is determined through DAVID and ranks the significance of each annotation cluster based on the relatedness of the terms and the genes associated with them.
c This column summarizes the biological terms in the annotation clusters. The gene ontology (GO) terms were gathered based on the known annotation of the submitted genes with respect to biological process, cellular component, and molecular function; as well as biological pathway membership and protein domains. The number in parentheses indicate the number of differentially expressed genes contributing to the clustered term.
IGFBP1 contains a conserved RGD sequence that allows it to act as a ligand for the integrin heterodimer-␣5␤1 (27, 44) . Blocking antibodies against the ␣5␤1-integrin subunits inhibit trophoblast cell migration (43) , while IGFBP1 stimulated migration of trophoblast cells is attenuated by mutation of the RGD integrin binding sequence to WGD or pretreatment with an inhibitory peptide (27) . In sheep, the ␣5-and the ␤1-integrin subunits are constitutively expressed on the surface of uterine LE/sGE and conceptus trophectoderm (45) , which supports the hypothesis that LGALS15 and IGFBP1 stimulate migration and adhesion of trophectoderm cells to the ovine uterine LE (12) voltage-gated channel (6) GO:0022832ϳvoltage-gated channel activity (7) GO:0005244ϳvoltage-gated ion channel activity (7) GO:0022838ϳsubstrate specific channel activity (11) GO:0031420ϳalkali metal ion binding (7) GO:0022836ϳgated channel activity (9) Ionic channel (9) GO:0006810ϳtransport (49) GO:0005216ϳion channel activity (10) Transport (28) GO:0015672ϳmonovalent inorganic cation transport (9) GO:0051234ϳestablishment of localization (50) GO:0008324ϳcation transmembrane transporter activity (13) GO:0008076ϳvoltage-gated potassium channel complex (4) GO:0022843ϳvoltage-gated cation channel activity (5) GO:0005261ϳcation channel activity (7) GO:0005249ϳvoltage-gated potassium channel activity (4) potassium transport (4) GO:0006813ϳpotassium ion transport (5) IPR005821:Ion transport (4) Potassium (4) GO:0030955ϳpotassium ion binding (4) GO:0005267ϳpotassium channel activity (4) 1.03 GO:0001558ϳregulation of cell growth (7) GO:0016049ϳcell growth (7) GO:0008361ϳregulation of cell size (7) GO:0040008ϳregulation of growth (7) GO:0009653ϳanatomical structure morphogenesis (24) GO:0000902ϳcell morphogenesis (12) GO:0032989ϳcellular structure morphogenesis (12) GO:0040007ϳgrowth (8) 15 0.98 GO:0044255ϳcellular lipid metabolic process (16) GO:0006629ϳlipid metabolic process (18) GO:0008610ϳlipid biosynthetic process (7) a The 15 most significant annotation clusters identified based on the gene list submitted for analysis through DAVID.
c This column summarizes the biological terms in the annotation clusters. The GO terms were gathered based on the known annotation of the submitted genes with respect to biological process, cellular component, and molecular function; as well as biological pathway membership and protein domains. The number in parenthesis indicate the number of differentially expressed genes contributing to the clustered term.
during the attachment phase of implantation. Indeed, the induction and stimulation of LGALS15 and IGFBP1 by uterine LE with advancing day of pregnancy and early P4 correlate with the onset of growth and developmental elongation of the blastocyst to form a filamentous conceptus (72, 81, 82) . Although the LGALS15 gene is present in cattle and sheep, LGALS15 is not expressed in the bovine uterus (57) . Thus, IGFBP1 may play a central role in mediating conceptusendometrial interactions required for blastocyst elongation and implantation in sheep and cattle (71) . Despite markedly different implantation schemes among primates, rodents, and ruminants, upregulation of IGFBP1 in the endometrium is implicated as a regulator of blastocyst implantation and placental growth and development in those species (26) .
In the present study, HSD11B1, LGALS15, and SLC5A1 were the only genes upregulated between days 9 and 12 of pregnancy and on both days 9 and 12 in P4-treated ewes. Those genes are expressed specifically in ovine uterine LE/sGE (29, 72, 89) . Previous studies found that P4 induces and IFNT stimulates both LGALS15 and SLC5A1 expression (21, 28, 29) . (3) GO:0032504ϳmulticellular organism reproduction (4) GO:0048609ϳreproductive process in a multicellular organism (4) GO:0022414ϳreproductive process (8) 9 1.18 GO:0016044ϳmembrane organization and biogenesis (10) Endocytosis (5) GO:0006897ϳendocytosis (7) GO:0010324ϳmembrane invagination (7) GO:0005768ϳendosome (5) GO:0016192ϳvesicle-mediated transport (9) 10 1.12 Plasma (6) blood coagulation (4) hsa04610:Complement and coagulation cascades (5) GO:0007596ϳblood coagulation (4) GO:0050817ϳcoagulation (4) GO:0007599ϳhemostasis (4) GO:0050878ϳregulation of body fluid levels (4) GO:0042060ϳwound healing (4) (8) 13 1.08 GO:0046983ϳprotein dimerization activity (10) GO:0042803ϳprotein homodimerization activity (6) GO:0042802ϳidentical protein binding (7) 14 0.05 hsa00140:C21-Steroid hormone metabolism (3) GO:0016616ϳoxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (5) GO:0016614ϳoxidoreductase activity, acting on CH-OH group of donors (5) GO:0042445ϳhormone metabolic process (4) GO:0008202ϳsteroid metabolic process (5) hsa00150:Androgen and estrogen metabolism (3) 15 1.03 GO:0008015ϳblood circulation (6) GO:0003013ϳcirculatory system process (6) GO:0008217ϳregulation of blood pressure (3) a The 15 most significant annotation clusters identified based on the gene list submitted for analysis through DAVID.
c This column summarizes the biological terms in the annotation clusters. The GO terms were gathered based on the known annotation of the submitted genes with respect to biological process, cellular component, and molecular function; as well as biological pathway membership and protein domains. The number in parentheses indicates the number of differentially expressed genes contributing to the clustered term.
In fact, early P4 treatment advances expression of genes in the LE/sGE and development of elongated filamentous conceptuses on day 12 that produce more IFNT (72) . Based on our previous studies of LGALS15 and SLC5A1 expression in the ovine uterus (21, 29) , HSD11B1 expression in the ovine endometrial LE/sGE will likely be induced by P4 and stimulated by IFNT. Of note, DAVID analysis identified steroid metabolism and intracellular signaling cascades as biological processes affected by day of pregnancy and early P4 treatment. HSD11B1 is one of two isoforms of 11␤-hydroxysteroid dehydrogenase that modulate the actions of glucocorticoids (cortisol and corticosterone) within potential target cells (see Ref.
64 for review). HSD11B1 acts predominantly as an NADP(H)-dependent reductase to generate active cortisol or corticosterone. Cortisol can activate both the glucocorticoid receptor (nuclear receptor subfamily 3, group C, member 1 or NR3C1) and the mineralocorticoid receptor (nuclear receptor subfamily 3, group C, member 2 or NR3C2 or MR). The actions of liganded MR include increased sodium retention, water flux, and potassium secretion in organs such as the kidney. HSD11B1, as well as MR and GR, is expressed in secretory phase endometria as well as uterine decidua in women (62); however, the physiological roles of glucocorticoids in endometrial function has not been elucidated for any species. Expression of MR and GR in the ovine uterus during early pregnancy has not been reported, although GR are expressed in endometrial epithelia and placenta during late pregnancy (34) , and GR are expressed in endometria of cyclic cattle (53) . Moreover, expression of MR was upregulated in the endometrium of day 12 pregnant ewes in the present study. In the ovine uterus, PGR expression declines after day 6 and is absent after day 11 in both cyclic and pregnant ewes due to downregulation by P4 (80, 88) . The loss of detectable PGR in the endometrial LE/sGE is associated with the onset of expression of many genes, including GRP, LGALS15, prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (PTGS2), and SLC5A1 (21, 29, 50, 75) . Of particular note, prostaglandins can stimulate HSD11B1 activity in the placenta and glucocorticoids increase prostaglandin synthesis by upregulating expression and activities of phospholipase A2 and PTGS2 (see Ref. 63) , thereby establishing a positive feedforward loop implicated in the timing of parturition (13) . Therefore, HSD11B1 may be involved in the production of prostaglandins by the ovine endometrium during early pregnancy as well as the local production of cortisol in bovine endometrium (53) . Active cortisol generated by HSD11B1 in uterine LE/sGE could activate GR and increase expression of many target genes that contain glucocorticoid response elements (GRE). Future studies need to address the role of HSD11B1 in regulation of endometrial function with a focus on prostaglandins, which are essential for establishment of pregnancy in mice and implicated similarly in other species (49) . Moreover, expression of other genes associated with steroid metabolism, aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4) (AKR1C4), apolipoprotein B [including Ag(x) antigen] (APOB), hydroxy-delta-5-steroid dehydrogenase, 3 beta-and steroid delta-isomerase 1 (HSD3B1), and oxysterol binding protein-like 3 (OSBPL3) increased in the endometrium between days 9 and 12 of pregnancy in the present study.
DAVID analysis also identified lipid biosynthesis and metabolism as biological processes affected by day of pregnancy and early P4 treatment. These biological processes related to the biosynthesis of prostaglandins, such as PGE2, are potent angiogenic factors. In the present study, upregulation of PTGER4 (prostaglandin E receptor 4 or EP4) between days 9 and 12 of pregnancy is coordinated with increases in PTGS2 in endometrial LE/sGE (14) and prostaglandin production by the endometrium and blastocyst (14, 56) . Furthermore, an increase in hydroxyprostaglandin dehydrogenase 15-(NAD) (HPGD), also known as prostaglandin dehydrogenase 1 or PGDH, on day 12 may be important in converting prostaglandins, e.g., PGF, to biologically inactive 15-keto derivatives. The biological roles of prostaglandins during early pregnancy have not been elucidated in sheep, although they play a critical role in implantation in rodents and perhaps humans (16, 49) . Increased expression of genes associated with angiogenesis, von Willebrand factor (VWF), slit homolog 2 (Drosophila) (SLIT2), slit homolog 3 (Drosophila) (SLIT3), hepatocyte growth factor (hepapoietin A; scatter factor) (HGF), CTGF, and angiopoietin-related protein 3 precursor (ANGPTL3), were also found to be upregulated in the endometrium on day 12 of pregnancy. Indeed, DAVID analysis identified blood circulation and circulatory system process as biological processes affected by day of pregnancy and early P4 treatment. Although angiogenesis has not been well studied during early pregnancy in ruminants, increases in uterine blood flow do occur during early pregnancy in sheep (68) .
DAVID analysis identified several clusters of genes involved in response to external stimulus, inflammatory response, and defense response as biological processes affected by day of pregnancy and early P4 treatment. Indeed, many of the genes upregulated by day of pregnancy and early P4 treatment are implicated in protection of the endometrium from infection by pathogens such as bacteria and viruses [C-type lectin domain family 2, member B (CLEC2B), C-type lectin domain family 2, member E (CLEC2E), C-type lectin domain family 4, member B (CLEC4B), cystatin C (CST3), cystatin E/M (CST6), defensin, beta 1 (DEFB1), DEAD (Asp-Glu-Ala-Asp) box polypeptide 52 (DDX52), DEAD (AspGlu-Ala-Asp) box polypeptide 58 (DDX58), guanylate binding protein 2, interferon-inducible (GBP2), interferon, alpha-inducible protein 6 (IFI6), interferon, alpha-inducible protein 16 (IFI16), interferon, alpha-inducible protein 27 (IFI27), interferon induced with helicase C domain 1 (IFIH1), interferon-induced protein with tetratricopeptide repeats 3 (IFIT3), ISG15, N-myc (and STAT) interactor (NMI), myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse MX1), 2Ј-5Ј-oligoadenylate synthetase-like (OASL), 2Ј,5Ј-oligoadenylate synthetase 1, 40/46 kDa (OAS1), phospholipid scramblase 2 (PLSCR2), and toll-like receptor 4 (TLR4)], as well as immunomodulation (CXCL14 and cytotoxic T-lymphocyte-associated protein 4 or CTLA4), which is likely critical for protection of the uterus during pregnancy and after parturition (36, 39) . In addition, many of those genes are classical IFN-stimulated genes or ISGs upregulated by type I IFNs. For instance, CXCL14, a novel CXC chemokine of 77 amino acids, is expressed constitutively in many normal tissues, but highest in epithelial cells (52) . Consistent with chemokine attraction of hematopoietic cells, CXCL14 induces migration in the activated macrophage THP-1 cell line and other cells of macrophage lineages including monocytes and dendritic cells (52, 74) . From these studies, it is hypothesized that CXCL14 may play a role in the maturation of monocytes to macrophages and dendritic cells. In the present study, CXCL14 mRNA was expressed exclusively in the endometrial LE and GE. Although the role of CXCL14 in the uterus has not been investigated in any species, dendritic cells are hypothesized to have an immunoregulatory role in the maintenance of pregnancy and, in mice, to regulate implantation, decidual vascular development, and placental development (46, 51) . CLEC2B, CLEC2E, and CLEC4E are members of the C-type lectin/C-type lectin-like domain (CTL/CTLD) superfamily that share a common protein fold and have diverse functions, such as cell adhesion, cell-cell signaling, glycoprotein turnover, and roles in inflammation and immune responses (86) . The membrane-associated C-type lectin receptors (CLRs) recognize glycan structures expressed by host cells of the immune system or on specific tissues, which upon recognition allow cellular interactions between dendritic cells and other immune or tissue cells. In addition, CLRs can function as pathogen recognition receptors. In the present study, many classical ISGs (i.e., ISG15, IFIT3, NMI, MX1, IFI35, OASL, OAS1, CST6, IFIH1, PLSCR2) were increased on day 12 of pregnancy and upregulated on day 12 in ewes treated with P4, which is consistent with those ewes containing an elongated filamentous conceptus producing more IFNT than the normal blastocyst on day 12 (72) . Similar to other type I IFNs, IFNT induces or stimulates a large number of ISGs in the ruminant uterus that are hypothesized to be involved in protection of the uterus and conceptus from viruses as well as establishment of uterine receptivity to blastocyst implantation (35, 38, 81, 84) . Interestingly, many ISGs are also upregulated in decidualized human stromal cells incubated in trophoblast-conditioned medium (40) and are upregulated in the uterine decidua of mice (3, 4) . Therefore, the induction and upregulation of ISGs in the uterine stroma of ruminants and decidua in mice, primates, and humans appear to be a common response of the uterus to the conceptus.
Regulation of conceptus implantation involves a delicate balance between proteases and their inhibitors, and DAVID analysis identified biological processes involving protease, peptidase activity, and proteolysis as a biological process in the endometrium affected by day of pregnancy and early P4 treatment. In the present study, two cysteine protease inhibitors, CST3 and CST6, and a zinc metalloprotease (MEP1B) were upregulated on day 12 and by early P4 in day 12 ewes. CST3, an inhibitor of capthesin L, is expressed in ovine endometrial LE/sGE and conceptus trophectoderm (76, 77) , and induced by P4 and stimulated by IFNT in endometrial LE/sGE (77). CST6 has not been studied in the ovine uterus but is upregulated in bovine endometria during diestrus (65) . CST6 (cystatin E/M) is a cysteine proteinase inhibitor that shows moderate inhibition of cathepsin B, but not cathepsin C. CTSB is expressed abundantly in ovine conceptus trophectoderm during early pregnancy (77) . The induction and increase in expression of specific cysteine protease inhibitors in endometrial LE/sGE likely regulate the activity of cathepsins expressed in conceptus trophectoderm to limit invasion during implantation (77, 84) . Several other enzymes, such as hexosaminidase B (beta polypeptide) (HEXB), were upregulated on day 12 of pregnancy and by early P4 on day 12. Indeed, P4 stimulates the amount of HEXB and other lysosomal-like enzymes in the uterine lumen of sheep, pigs, and horses (37) . The HEXB gene encodes the beta subunit of the enzyme hexosaminidase that hydrolyzes glycoproteins, glucosaminoglycans, and glycolipids. These enzymes and others present in the uterine lumen likely modify proteins on the endometrial epithelium and trophoblast, as well as modify proteins before uptake by the trophoblast.
Although much of this discussion has focused on genes coordinately upregulated by day of pregnancy and early P4 treatment, a number of genes decreased between days 9 and 12 of pregnancy and as a result of early P4 treatment (see Fig. 2 ). A hallmark of pregnancy recognition signaling by IFNT is its inhibition of estrogen receptor alpha (ESR1) gene transcription (79) and, accordingly, ESR1 was lower in endometria on day 12 of pregnancy in the present study. It was more difficult to organize the downregulated genes into common genes and pathways, although several enzymes [ANPEP, LPL, and matrix metallopeptidase 14 (membraneinserted) or MMP14] were lower on day 12 of pregnancy and day 9 in early P4-treated ewes (ANPEP and LPL). ANPEP, an aminopeptidase that plays a role in the final digestion of peptides generated from hydrolysis of proteins by gastric and pancreatic proteases, has not been well studied for function in other tubular organs. Downregulation of ANPEP may allow proteins to be absorbed intact by the trophoblast. The primary function of LPL (lipoprotein lipase) is the hydrolysis of triglycerides of circulating chylomicrons and very low density lipoproteins (VLDL). The loss of LPL could allow for increased storage of lipids in the endometrium that are needed for blastocyst nutrition and prostaglandin production. As mentioned previously, continuous exposure of the uterus to P4 downregulates expression of PGR in uterine epithelia by day 13 in ewes. In the present study, expression of both sonic hedgehog homolog (Drosophila) (SHH) and Indian hedgehog homolog (Drosophila) (IHH) mRNA decreased between days 9 and 12 of pregnancy; however, they are regulated by P4 in uterine GE of mice and required for implantation (54, 55) . The decline in IHH and SHH in the endometria of the ovine uterus is associated with the loss of PGR in the uterine epithelia, and IHH is expressed in the endometrial GE (M. Aires and T.E. Spencer, unpublished results). It is likely that the protracted nature of implantation in sheep may be responsible for differences in IHH and SHH expression between sheep and mice. Another gene downregulated between days 9 and 12 of pregnancy and in day 9 ewes receiving early P4 was MIF. MIF was expressed in the endometrial epithelia on day 9 in CO-treated ewes and encodes a lymphokine involved in cell-mediated immunity, immunoregulation, and inflammation. IFNG was also downregulated between days 9 and 12 of pregnancy, although it was not localized in the present study. IFNG (interferon gamma) is a type II IFN that is generally produced by lymphocytes, is a potent activator of macrophages, and has antiproliferative effects on transformed cells. Thus, the loss of MIF and IFNG may be important in terms of the inability of the uterus to recognize the semiallogenic blastocyst.
The microarray study reported here represents our continuing efforts to identify genes and biological pathways in the endometrium that regulate peri-implantation blastocyst growth and development (28, 84, 85) . Moreover, the genes identified in these studies may be useful for development of pregnancy recognition tests (24) and identification of bio-markers for uterine receptivity and early pregnancy success that can be used to select individuals with enhanced fertility. These biomarkers are needed, because histological analyses of endometria are not useful to predict fertility (1) and the heritability of fertility traits is very low. Many of the genes and pathways identified in our studies are conserved in cattle as well as in humans and mice (see Refs. 1, 6, 94) . Thus, further analyses of the genes identified in the present study will have biological implications for animal agriculture and biomedicine.
